BioCardia, Inc.

NasdaqCM:BCDA Stock Report

Market Cap: US$12.5m

BioCardia Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:BCDA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Dec 25BuyUS$1,170Peter AltmanIndividual900US$1.30
16 Dec 25BuyUS$274Peter AltmanIndividual200US$1.37
19 Sep 25BuyUS$60,000Peter AltmanIndividual48,000US$1.25
19 Sep 25BuyUS$360,000Andrew BlankIndividual288,000US$1.25
19 Sep 25BuyUS$498,000Simon StertzerIndividual398,400US$1.25
22 Aug 25BuyUS$1,281Peter AltmanIndividual700US$1.83
13 Aug 25BuyUS$183Peter AltmanIndividual100US$1.83
12 Aug 25BuyUS$700Peter AltmanIndividual400US$1.75
11 Aug 25BuyUS$2,989Peter AltmanIndividual1,700US$1.76
30 Jun 25BuyUS$49,999Peter AltmanIndividual24,096US$2.08
30 Jun 25BuyUS$9,999David McClungIndividual4,819US$2.08
30 Jun 25BuyUS$150,000Simon StertzerIndividual72,289US$2.08
30 Jun 25BuyUS$150,000Andrew BlankIndividual72,289US$2.08
30 May 25BuyUS$221Peter AltmanIndividual100US$2.21
22 May 25BuyUS$4,651Peter AltmanIndividual2,300US$2.08
16 May 25BuyUS$730Peter AltmanIndividual300US$2.43
14 May 25BuyUS$299Peter AltmanIndividual100US$2.99
23 Apr 25BuyUS$49,999Peter AltmanIndividual26,246US$1.91
23 Apr 25BuyUS$24,999William FacteauIndividual13,123US$1.91
23 Apr 25BuyUS$249,999Andrew BlankIndividual131,233US$1.91
23 Apr 25BuyUS$24,999David McClungIndividual13,123US$1.91
23 Apr 25BuyUS$199,998Simon StertzerIndividual104,986US$1.91
23 Apr 25BuyUS$24,999Richard KrasnoIndividual13,123US$1.91
15 Apr 25BuyUS$214Peter AltmanIndividual100US$2.14
11 Apr 25BuyUS$609Peter AltmanIndividual300US$2.03
10 Apr 25BuyUS$597Peter AltmanIndividual300US$1.99
07 Apr 25BuyUS$980Peter AltmanIndividual500US$1.96
04 Apr 25BuyUS$1,632Peter AltmanIndividual800US$2.04
03 Apr 25BuyUS$2,688Peter AltmanIndividual1,200US$2.24
03 Apr 25BuyUS$2,435Peter AltmanIndividual1,100US$2.23
05 Mar 25BuyUS$2,450Simon StertzerIndividual1,000US$2.45
04 Mar 25BuyUS$35,733Simon StertzerIndividual15,536US$2.30
03 Mar 25BuyUS$1,055Peter AltmanIndividual500US$2.11
03 Mar 25BuyUS$52,332Simon StertzerIndividual22,753US$2.30
07 Feb 25BuyUS$1,488Peter AltmanIndividual600US$2.48
30 Jan 25BuyUS$1,769Peter AltmanIndividual739US$2.40

Insider Trading Volume

Insider Buying: BCDA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BCDA?
Owner TypeNumber of SharesOwnership Percentage
Institutions427,1404.02%
Private Companies1,150,84710.8%
Individual Insiders2,254,87821.2%
General Public6,779,86963.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 131.5%.

Top Shareholders

Top 25 shareholders own 36.1% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.54%
Lincoln Alternative Strategies Llc
800,000US$944.0k0%no data
6.73%
Simon Stertzer
714,275US$842.8k0%no data
5.99%
Andrew Blank
636,058US$750.5k0%no data
3.61%
Thomas Satterfield
382,650US$451.5k198%no data
3.31%
A.G. Family L.P.
350,847US$414.0k217%no data
2.52%
Peter Altman
267,966US$316.2k23.6%no data
1.22%
CM Management, LLC
130,000US$153.4k0%0.12%
1.03%
Jim Allen
109,661US$129.4k0%no data
0.91%
The Vanguard Group, Inc.
96,498US$113.9k649%no data
0.72%
David McClung
76,887US$90.7k60.4%no data
0.37%
Susquehanna International Group, LLP
38,808US$45.8k0%no data
0.37%
Geode Capital Management, LLC
38,740US$45.7k3.41%no data
0.33%
Brown Advisory Incorporated
35,538US$41.9k0%no data
0.3%
Edward Gillis
31,874US$37.6k255%no data
0.18%
Two Sigma Securities, LLC
19,337US$22.8k0%no data
0.17%
Commonwealth Equity Services, LLC
18,283US$21.6k1.11%no data
0.16%
Wealth Enhancement Advisory Services, LLC
17,000US$20.1k0%no data
0.15%
Richard Krasno
16,268US$19.2k0%no data
0.15%
XTX Markets Limited
16,177US$19.1k0%no data
0.12%
William Facteau
13,123US$15.5k0%no data
0.1%
UBS Asset Management AG
10,740US$12.7k157%no data
0.034%
Jay Moyes
3,616US$4.3k0%no data
0.029%
Morgan Stanley
3,105US$3.7k0%no data
0.024%
Rebecca Satterfield
2,500US$3.0k0%no data
0.0098%
Pingora Partners LLC
1,036US$1.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/31 12:56
End of Day Share Price 2025/12/31 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioCardia, Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Joseph PantginisH.C. Wainwright & Co.